Published online Mar 6, 2024. doi: 10.12998/wjcc.v12.i7.1333
Peer-review started: November 12, 2023
First decision: January 9, 2024
Revised: January 17, 2024
Accepted: February 6, 2024
Article in press: February 6, 2024
Published online: March 6, 2024
Processing time: 109 Days and 23.7 Hours
Multiple primary malignant tumors (MPMTs) are rare type of cancer, especially when solid tumors are the first and lymphoma is the second primary malignancy. We report a patient with heterochronous MPMTs consisting of prostate cancer and rectal diffuse large B-cell lymphoma (DLBCL).
We report a 77-year-old male patient diagnosed with prostate cancer who was treated with radiation therapy and one year of endocrine therapy with bicaluta
Although rare, the possibility of prostate cancer combined with a double primary cancer of DLBCL can provide a deeper understanding.
Core Tip: We report the case of a 77-year-old male patient diagnosed with prostate cancer presenting with dysuria with hematuria. He received radiation therapy and 1 year of endocrine therapy with an efficacy evaluation of partial response. 7 years later, he was diagnosed with diffuse large B-cell lymphoma of the rectum with lung metastases presenting with lower abdominal pain and constipation, and was treated with 2 cycles of chemotherapy on the CHOP regimen with an efficacy evaluation of remission. He was not treated again for personal reasons and unfortunately, the patient died 1 year later.
